Admission and discharge treatment after first hospitalisation with heart failure
| Whites (n = 352) | South Asians (n = 176) | p Value | |
|---|---|---|---|
| *Fisher’s exact test. | |||
| ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker. | |||
| Admission | |||
| Aspirin | 98 (28%) | 50 (28%) | 0.891 |
| ACEI or ARB | 91 (26%) | 54 (31%) | 0.241 |
| Diuretic | 169 (48%) | 68 (39%) | 0.041 |
| Loop | 149 (42%) | 61 (35%) | 0.090 |
| Thiazide | 20 (6%) | 7 (4%) | 0.402 |
| β Blocker | 32 (9%) | 34 (19%) | 0.001 |
| CCB | 56 (16%) | 50 (28%) | 0.001 |
| Digoxin | 31 (9%) | 5 (3%) | 0.010 |
| Nitrate | 34 (10%) | 27 (15%) | 0.054 |
| Spironolactone | 3 (1%) | 1 (1%) | 1.000 |
| Statin | 26 (7%) | 9 (5%) | 0.322 |
| Discharge | |||
| Aspirin | 131 (43%) | 79(51%) | 0.139 |
| ACEI or ARB | 183 (61%) | 101 (65%) | 0.386 |
| Diuretic | 237 (78%) | 115 (74%) | 0.289 |
| Loop | 235 (78%) | 111 (72%) | 0.136 |
| Thiazide | 2 (1%) | 4 (3%) | 0.187* |
| β Blocker | 46 (15%) | 32 (21%) | 0.154 |
| CCB | 30 (10%) | 35 (22%) | 0.0003 |
| Digoxin | 65 (22%) | 11 (7%) | <0.0001 |
| Nitrate | 40 (13%) | 35 (20%) | 0.012 |
| Spironolactone | 21 (7%) | 8 (5%) | 0.447 |
| Statin | 54 (18%) | 22 (14%) | 0.303 |